Safety and Effectiveness Study of Imiquimod Creams for the Treatment of Actinic Keratoses (AKs)
Public ClinicalTrials.gov record NCT00603798. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-blinded, Placebo-controlled, Multicenter, Efficacy and Safety Study of Six Weeks of Treatment With Imiquimod Creams for Actinic Keratoses
Study identification
- NCT ID
- NCT00603798
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Graceway Pharmaceuticals, LLC
- Industry
- Enrollment
- 490 participants
Conditions and interventions
Conditions
Interventions
- Imiquimod cream Drug
- Placebo cream Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2007
- Primary completion
- Jun 30, 2008
- Completion
- Jun 30, 2008
- Last update posted
- Jun 28, 2010
2008
United States locations
- U.S. sites
- 26
- U.S. states
- 16
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | 35205 | — |
| Not listed | Little Rock | Arkansas | 72205 | — |
| Not listed | Encino | California | 91436 | — |
| Not listed | Vista | California | 92083 | — |
| Not listed | New Britain | Connecticut | 06052 | — |
| Not listed | New Haven | Connecticut | 06511 | — |
| Not listed | Coral Gables | Florida | 33134 | — |
| Not listed | West Palm Beach | Florida | 33401 | — |
| Not listed | Arlington Heights | Illinois | 60005 | — |
| Not listed | Champaign | Illinois | 61820 | — |
| Not listed | Carmel | Indiana | 46032 | — |
| Not listed | Evansville | Indiana | 47713 | — |
| Not listed | South Bend | Indiana | 46617 | — |
| Not listed | Louisville | Kentucky | 40202 | — |
| Not listed | Omaha | Nebraska | 68144 | — |
| Not listed | Reno | Nevada | 89509 | — |
| Not listed | Albuquerque | New Mexico | 87106 | — |
| Not listed | Portland | Oregon | 97223 | — |
| Not listed | Philadelphia | Pennsylvania | 19034 | — |
| Not listed | Nashville | Tennessee | 37203 | — |
| Not listed | Dallas | Texas | 75246 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | Houston | Texas | 77058 | — |
| Not listed | San Antonio | Texas | 78229 | — |
| Not listed | Norfolk | Virginia | 23507 | — |
| Not listed | Woodbridge | Virginia | 22191 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00603798, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 28, 2010 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00603798 live on ClinicalTrials.gov.